Home › Depression › Illinois › Joliet
Depression clinical trials in Joliet, IL
3 studies for Depression are looking for participants at sites in and around Joliet (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
RecruitingPhase 3
- Advanced Quality Medical Research, Orland Park · 14 mi away
E-Mindfulness Approaches for Living After Breast Cancer
RecruitingPhase 3
- Edward Hospital/Cancer Center?Plainfield, Plainfield · 9 mi away
- Northwestern Medicine Orland Park, Orland Park · 14 mi away
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
RecruitingPhase 3
- Advanced Quality Medical Research /ID# 272902, Orland Park · 14 mi away
About Depression
Depression is a serious medical illness. It affects almost 7 percent of U.S. adults. It causes feelings of sadness, hopelessness, and frustration that do not go away. Learn about treatments.
More about Depression on MedlinePlus
Depression trials in other cities
- Boston, MA52 studies
- New York City, NY45 studies
- Philadelphia, PA26 studies
- Atlanta, GA24 studies
- Chicago, IL24 studies
- Pittsburgh, PA22 studies
- San Diego, CA21 studies
- Charleston, SC19 studies
- Houston, TX18 studies
- Orlando, FL17 studies
- Los Angeles, CA17 studies
- Miami, FL16 studies
Other studies in Joliet
- Non-Small Cell Lung Cancer12 studies
- Lung Cancer12 studies
- Metastatic Cancer7 studies
- Bladder Cancer7 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Prostate Cancer5 studies
- Hypopharyngeal Cancer5 studies
- Laryngeal Cancer5 studies
- Oral Cancer5 studies
- Acute Myeloid Leukemia5 studies
- Breast Cancer4 studies
- Colon Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.